Shahbazian Heshmatollah, Zand Moghadam Ahmad, Ehsanpour Ali, Khazaali Mahyar
Department of Internal Medicine, Jondi Shapour University of Medical Sciences, Ahwaz, Iran.
Iran J Kidney Dis. 2009 Jul;3(3):151-5.
Purine metabolites constitute a major class of uremic toxins, and reliable characterization of which helps nephrologists to choose the most appropriate treatment for the patients individually. In the present study, we assessed plasma concentrations of hypoxanthine and uric acid as purine metabolites in patients on maintenance hemodialysis, before and after a dialysis session.
A total of 20 patients on maintenance hemodialysis were enrolled in this study. All of the patients underwent a routine 4-hour dialysis, as scheduled 3 times per week. Polysulfone membranes and bicarbonate dialysis solution were used in all dialysis sessions. Blood specimens were taken from the arteriovenous fistula immediately before and after one hemodialysis session, in order to measure plasma concentrations of hypoxanthine and uric acid by high-performance liquid chromatography, and to compare the predialysis and postdialysis values.
Before hemodialysis, the mean plasma hypoxanthine and uric acid concentrations were 18.93 +/- 8.28 micromol/L and 44.16 +/- 22.88 micromol/L, respectively. After hemodialysis, these concentrations reduced to 13.68 +/- 4.42 micromol/L and 15.61 +/- 11.12 micromol/L, respectively. Hypoxanthine concentration had a 27.7% decrease after hemodialysis (mean difference, 5.25 +/- 6.24 micromol/L; 95% confidence interval, 2.32 to 8.10; P < .001). Also, uric acid concentration decreased by 64.6% (mean difference, 28.55 +/- 14.39 micromol/L; 95% confidence interval, 21.81 to 32.28; P < .001).
Plasma concentrations of hypoxanthine and uric acid are higher than normal before hemodialysis, and they decrease significantly after hemodialysis; however, both of them may be still higher than normal values.
嘌呤代谢产物是尿毒症毒素的主要类别,对其进行可靠的特征分析有助于肾脏科医生为患者个体选择最合适的治疗方法。在本研究中,我们评估了维持性血液透析患者透析前后血浆中次黄嘌呤和尿酸这两种嘌呤代谢产物的浓度。
本研究共纳入20例维持性血液透析患者。所有患者均按每周3次的计划进行常规4小时透析。所有透析过程均使用聚砜膜和碳酸氢盐透析液。在一次血液透析治疗前后立即从动静脉内瘘采集血样,通过高效液相色谱法测定血浆中次黄嘌呤和尿酸的浓度,并比较透析前和透析后的数值。
血液透析前,血浆次黄嘌呤和尿酸的平均浓度分别为18.93±8.28微摩尔/升和44.16±22.88微摩尔/升。血液透析后,这些浓度分别降至13.68±4.42微摩尔/升和15.61±11.12微摩尔/升。血液透析后次黄嘌呤浓度下降了27.7%(平均差值为5.25±6.24微摩尔/升;95%置信区间为2.32至8.10;P<.001)。此外,尿酸浓度下降了64.6%(平均差值为28.55±14.39微摩尔/升;95%置信区间为21.81至32.28;P<.001)。
血液透析前血浆中次黄嘌呤和尿酸的浓度高于正常水平,血液透析后显著降低;然而,两者可能仍高于正常数值。